Valeritas Announces Presentation of Preclinical h-PatchTM CBD Study at CannMed Conference
(WorldNews Health)

BRIDGEWATER, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, which uses its proprietary h-PatchTM technology, announced today data from its preclinical pharmacokinetic (PK) study of cannabidiol (CBD) subcutaneous infusion delivered via its h-PatchTM wearable drug delivery device have been accepted for a poster presentation at the annual CannMed Conference in Pasadena, CA, on September 23-24, 2019. CannMed is an industry conference focused on understanding the medical benefits and complex science of cannabis. Tuesday, September 24, 2019 10:00 AM - 11:00 AM ET Pharmacokinetic...